- Title
- Sotagliflozin, a Dual SGLT1 and SGLT2 Inhibitor, as Adjunct Therapy to Insulin in Type 1 Diabetes
- Creators
- A. T. Sands (Author)B. P. Zambrowicz (Author)J. Rosenstock (Author)P. Lapuerta (Author)B. W. Bode (Author)S. K. Garg (Author)J. B. Buse (Author)P. Banks (Author)R. Heptulla (Author)Marc S. Rendell (Author) - Creighton UniversityW. T. Cefalu (Author)P. Strumph (Author)
- Additional links
- http://doi.org/10.2337/dc14-2806
- Publication Details
- Diabetes Care, Vol.38(7), pp.1181-1188
- Publisher
- by the American Diabetes Association. Readers may use this article as long as the work is properly cited, the use is educational and not for profit, and the work is not altered
- Number of pages
- 1181-1188
- Identifiers
- 991005932393902656
- Academic Unit
- School of Medicine; Endocrine
- Language
- English
- Resource Type
- Journal article
Journal article
Sotagliflozin, a Dual SGLT1 and SGLT2 Inhibitor, as Adjunct Therapy to Insulin in Type 1 Diabetes
Diabetes Care, Vol.38(7), pp.1181-1188
07/2015
PMID: 26049551
Metrics
4 Record Views